Relay Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Relay Therapeutics

08/08/2023 23:02

* Relay Therapeutics Inc  RLAY.OQ  reported a quarterly
adjusted
loss of 81 cents​​ per share for the quarter ended in June. The
mean expectation of twelve analysts for the quarter was for a
loss of 82 cents per share.
    * Revenue fell 67.4% to $119.00 thousand from a year ago;
analysts
expected $693.00 thousand. 
    * Relay Therapeutics Inc's reported EPS for the quarter was
a loss
of 81 cents​.
    * The mean earnings estimate of analysts had fallen by
about 1.8%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Relay Therapeutics Inc shares had fallen by 17.4% this
quarter and lost 30.6% so far this year.
    * The company reported a quarterly loss of $98.51 million.
    * Wall Street's median 12-month price target for Relay
Therapeutics Inc is $28.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 12 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 8 at 10:02 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.82          -0.81          Beat
 Mar. 31 2023      -0.69          -0.78          Missed
 Dec. 31 2022      -0.70          -0.56          Beat
 Sep. 30 2022      -0.71          -0.76          Missed